Measures in PRIME - Prime Registry

Download the 2026 Measures (xls)

wdt_ID	wdt_created_by	wdt_created_at	wdt_last_edited_by	wdt_last_edited_at	PRIME ID	QPP# / Quality#	eCQM#	Measure Title	Description
134	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	12	369	158	Pregnant women that had HBsAg testing	This measure identifies pregnant women who had a HBsAg (hepatitis B) test during their pregnancy.
135	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	35	66	146	Appropriate Testing for Children with Pharyngitis	Percentage of children 3-18 years of age who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episode.
136	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	36	236	165	Controlling High Blood Pressure	Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period.
137	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	37	238	156	Use of High-Risk Medications in the Elderly	Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication. 2) Percentage of patients who were ordered at least two of the
138	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	38	239	155	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents	Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. Three rates are reported -Percentage of pat
139	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	39	226	138	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.
140	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	40	112	125	Breast Cancer Screening	Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer
141	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	41	309	124	Cervical Cancer Screening	Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: * Women age 21-64 who had cervical cytology performed every 3 years * Women age 30-64 who had cervical cytology/human papillomavirus (HPV
142	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	42	310	153	Chlamydia Screening for Women	Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period
143	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	43	113	130	Colorectal Cancer Screening	Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer.
144	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	44	311	126	Use of Appropriate Medications for Asthma	Percentage of patients 5-64 years of age who were identified as having persistent asthma and were appropriately ordered medication during the measurement period
145	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	45	240	117	Childhood Immunization Status	Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); three H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumoc
146	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	46	110	147	Preventive Care and Screening: Influenza Immunization	Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization.
147	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	47	111	127	Pneumococcal Vaccination Status for Older Adults	Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
148	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	48	312	166	Use of Imaging Studies for Low Back Pain	Percentage of patients 18-50 years of age with a diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of the diagnosis.
149	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	49	117	131	Diabetes: Eye Exam	Percentage of patients 18-75 years of age with diabetes who had a retinal or dilated eye exam by an eye care professional during the measurement period or a negative retinal exam (no evidence of retinopathy) in the 12 months prior to the measurement perio
150	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	50	163	123	Diabetes: Foot Exam	The percentage of patients 18-75 years of age with diabetes (type 1 and type 2) who received a foot exam (visual inspection and sensory exam with mono filament and a pulse exam) during the measurement year
151	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	51	1	122	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)	Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period.
152	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	53	119	134	Diabetes: Medical Attention for Nephropathy	The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period.
153	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	54	2	163	Diabetes: Low Density Lipoprotein (LDL-C) Control (< 100 mg/dL)	Percentage of patients 18-75 years of age with diabetes whose LDL-C was adequately controlled (<100 mg/dL) during the measurement period.
154	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	55	204	164	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet	The percentage of patients 18 years of age and older who were discharged from an inpatient setting with an acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) during the 12 months prior to th
155	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	56	65	154	Appropriate Treatment for Children with Upper Respiratory Infection (URI)	Percentage of children 3 months-18 years of age who were diagnosed with upper respiratory infection (URI) and were not dispensed an antibiotic prescription on or three days after the episode.
156	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	57	7	145	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)	Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior MI or a current or prior LVEF <40% who were prescribed beta-blocker therapy.
157	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	58	241	182	Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control (<100 mg/dL)	Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who ha
158	primecreativeteam	08/04/2026 03:37 PM	primecreativeteam	08/04/2026 03:37 PM	59	5	135	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)	Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12-month period when seen in the